These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31757682)
1. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase. Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682 [TBL] [Abstract][Full Text] [Related]
2. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase. Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888 [TBL] [Abstract][Full Text] [Related]
3. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines. Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544 [TBL] [Abstract][Full Text] [Related]
4. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity. Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of isothiazolo[4,5- Ivanova Y; Spittaels S; Gao LJ; Schols D; Van Meervelt L; Froeyen M; Dehaen W; De Jonghe S Org Biomol Chem; 2024 Sep; 22(36):7373-7389. PubMed ID: 39171941 [TBL] [Abstract][Full Text] [Related]
6. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents. Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739 [TBL] [Abstract][Full Text] [Related]
7. A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase. Wouters R; Tian J; Herdewijn P; De Jonghe S ChemMedChem; 2019 Jan; 14(2):237-254. PubMed ID: 30548533 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity. Verdonck S; Pu SY; Sorrell FJ; Elkins JM; Froeyen M; Gao LJ; Prugar LI; Dorosky DE; Brannan JM; Barouch-Bentov R; Knapp S; Dye JM; Herdewijn P; Einav S; De Jonghe S J Med Chem; 2019 Jun; 62(12):5810-5831. PubMed ID: 31136173 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of a 3,7-Disubstituted Isothiazolo[4,3- Grisez T; Ravi NP; Froeyen M; Schols D; Van Meervelt L; De Jonghe S; Dehaen W Molecules; 2024 Feb; 29(5):. PubMed ID: 38474466 [TBL] [Abstract][Full Text] [Related]
10. Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline Inhibitors. Asquith CRM; Tizzard GJ; Bennett JM; Wells CI; Elkins JM; Willson TM; Poso A; Laitinen T ChemMedChem; 2020 Jul; 15(13):1200-1215. PubMed ID: 32358915 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5- Xu J; Xie X; Ye N; Zou J; Chen H; White MA; Shi PY; Zhou J J Med Chem; 2019 Sep; 62(17):7941-7960. PubMed ID: 31403780 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a series of 1H-pyrrolo[2,3-b]pyridine compounds as potent TNIK inhibitors. Yang B; Wu Q; Huan X; Wang Y; Sun Y; Yang Y; Liu T; Wang X; Chen L; Xiong B; Zhao D; Miao Z; Chen D Bioorg Med Chem Lett; 2021 Feb; 33():127749. PubMed ID: 33340663 [TBL] [Abstract][Full Text] [Related]
13. Discovery of dual death-associated protein related apoptosis inducing protein kinase 1 and 2 inhibitors by a scaffold hopping approach. Gao LJ; Kovackova S; Sála M; Ramadori AT; De Jonghe S; Herdewijn P J Med Chem; 2014 Sep; 57(18):7624-43. PubMed ID: 25178155 [TBL] [Abstract][Full Text] [Related]
14. Isothiazolo[4,3- Li J; Kovackova S; Pu S; Rozenski J; De Jonghe S; Einav S; Herdewijn P Medchemcomm; 2015 Sep; 6(9):1666-1672. PubMed ID: 26925208 [TBL] [Abstract][Full Text] [Related]
16. Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation. Diab S; Teo T; Kumarasiri M; Li P; Yu M; Lam F; Basnet SK; Sykes MJ; Albrecht H; Milne R; Wang S ChemMedChem; 2014 May; 9(5):962-72. PubMed ID: 24677692 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors. Abdelaziz AM; Basnet SKC; Islam S; Li M; Tadesse S; Albrecht H; Gerber C; Yu M; Wang S Bioorg Med Chem Lett; 2019 Sep; 29(18):2650-2654. PubMed ID: 31362920 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors. Sabat M; Wang H; Scorah N; Lawson JD; Atienza J; Kamran R; Hixon MS; Dougan DR Bioorg Med Chem Lett; 2017 May; 27(9):1955-1961. PubMed ID: 28359790 [TBL] [Abstract][Full Text] [Related]
20. Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition. Reich SH; Sprengeler PA; Chiang GG; Appleman JR; Chen J; Clarine J; Eam B; Ernst JT; Han Q; Goel VK; Han EZR; Huang V; Hung INJ; Jemison A; Jessen KA; Molter J; Murphy D; Neal M; Parker GS; Shaghafi M; Sperry S; Staunton J; Stumpf CR; Thompson PA; Tran C; Webber SE; Wegerski CJ; Zheng H; Webster KR J Med Chem; 2018 Apr; 61(8):3516-3540. PubMed ID: 29526098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]